Back to Search Start Over

CSL invests in company using GMO cows for COVID-19 therapy

Source :
Legal Monitor Worldwide. April 10, 2020
Publication Year :
2020

Abstract

Blood products giant CSL is making its second foray into the COVID-19 fight, providing an undisclosed amount of early-stage funding to a biotech developing an immunotherapy treatment using human antibodies [...]

Subjects

Subjects :
Genetically modified animals -- Usage
Cattle industry -- Usage -- Investments
Immunotherapy -- Usage
Biological products -- Usage
Beef cattle
Antibodies
Genetically modified organisms
Backup software
Biotechnology
Company investment
Business, international
Law

Details

Language :
English
Database :
Gale General OneFile
Journal :
Legal Monitor Worldwide
Publication Type :
News
Accession number :
edsgcl.619990821

Tools

Authors Abstract Subjects Details